Suppr超能文献

软组织肉瘤。508例患者的流行病学及预后

Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.

作者信息

Gustafson P

机构信息

Department of Orthopedics, Lund University, Sweden.

出版信息

Acta Orthop Scand Suppl. 1994 Jun;259:1-31.

PMID:8042499
Abstract

We have evaluated epidemiology, prognosis and the association between metastases and local recurrence in a series of adult patients with soft tissue sarcoma (STS) of the extremity and trunk wall. 508 patients were diagnosed in the Southern Swedish Health Care Region from 1964 through 1989. The series was population-based, i.e., all patients within a defined area were included, irrespective of where treated, thereby avoiding selection bias in referral and follow-up. Epidemiology. The annual incidence was 18 per million. The median age was 64 years. One third of the tumors were subcutaneous, and these were smaller than the deep-seated tumors. Malignant fibrous histiocytoma and grade IV were the commonest. Differences were noted in clinicopathologic features among histotypes. The 5-year metastasis-free survival rate (MFSR) was 0.6. The crude local recurrence rate was 0.3. The majority of metastases and local recurrences occurred within 3 years. The referral pattern to the tumor center has become more favorable over time; in the last 5 years half of the subcutaneous and four fifths of the deep-seated tumors were referred before surgery. Prognostic factors. Tumor size, tumor necrosis, and vascular invasion were strong and independent prognostic factors for metastasis in a histologically mixed series. In MFH, storiform and pleomorphic subtype, tumor necrosis and tumor size were associated with a poor prognosis. Tumor necrosis and vascular invasion independently worsened the prognosis in leiomyosarcoma. In liposarcoma, tumor necrosis and in synovial sarcoma, tumor size were the only important prognostic factors. Tumor size, tumor necrosis, and vascular invasion were used in a prognostic system which identified two thirds of all patients with a 5-year MFSR of 0.8 and one third of the patients with a 5-year MFSR of 0.3. Metastasis and local recurrence. The causal association proposed for local recurrence and metastasis should be interpreted with caution. We suggest that highly malignant tumors combine local and distant aggressiveness, and that local recurrence is a marker of risk, and not necessarily a cause of, metastasis. Conclusions. 1. Population-based series are preferable when studying epidemiology in soft tissue sarcoma. 2. We propose that tumor size, tumor necrosis, and vascular invasion are strong and reliable factors that can be used to improve prognostic accuracy. 3. There is a growing body of evidence against a causal relationship between local recurrence and metastasis.

摘要

我们评估了一系列四肢及躯干壁软组织肉瘤(STS)成年患者的流行病学、预后以及转移与局部复发之间的关联。1964年至1989年期间,瑞典南部医疗保健地区诊断出508例患者。该系列研究基于人群,即纳入了特定区域内的所有患者,无论其接受治疗的地点,从而避免了转诊和随访中的选择偏倚。流行病学。年发病率为百万分之18。中位年龄为64岁。三分之一的肿瘤位于皮下,且这些肿瘤比深部肿瘤小。恶性纤维组织细胞瘤和IV级肿瘤最为常见。不同组织学类型的临床病理特征存在差异。5年无转移生存率(MFSR)为0.6。粗局部复发率为0.3。大多数转移和局部复发发生在3年内。随着时间推移,转诊至肿瘤中心的模式变得更加有利;在过去5年中,一半的皮下肿瘤和五分之四的深部肿瘤在手术前被转诊。预后因素。在组织学混合系列中,肿瘤大小、肿瘤坏死和血管侵犯是转移的强有力且独立的预后因素。在恶性纤维组织细胞瘤的席纹状和多形性亚型中,肿瘤坏死和肿瘤大小与预后不良相关。肿瘤坏死和血管侵犯独立地使平滑肌肉瘤的预后恶化。在脂肪肉瘤中,肿瘤坏死是唯一重要的预后因素;在滑膜肉瘤中,肿瘤大小是唯一重要的预后因素。肿瘤大小、肿瘤坏死和血管侵犯被用于一个预后系统,该系统识别出三分之二的5年MFSR为0.8的患者和三分之一的5年MFSR为0.3的患者。转移与局部复发。对于局部复发和转移之间的因果关联应谨慎解读。我们认为,高度恶性肿瘤兼具局部和远处侵袭性,局部复发是风险的一个标志,而不一定是转移的原因。结论。1. 在研究软组织肉瘤的流行病学方面,基于人群的系列研究更可取。2. 我们提出肿瘤大小、肿瘤坏死和血管侵犯是可用于提高预后准确性的强有力且可靠的因素。3. 越来越多的证据反对局部复发与转移之间的因果关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验